Q32 Bio Inc. (QTTB) Executive Compensation
Q32 Bio Inc. (QTTB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: QTTB
CIK: 1661998
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerElise Hanaoka
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-14 | 2026-10-06 | 4 | 0001193125-26-421836 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-06 | 4 | 0001193125-26-421835 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-06 | 4 | 0001193125-26-421834 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-10-09 | — | SCHEDULE 13G Filing | 0001231919-26-001441 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001193125-26-408435 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001193125-26-389836 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | 4 | 0001193125-26-371292 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | 4 | 0001193125-26-371293 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | 4 | 0001193125-26-371291 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005496 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000919574-26-005207 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001193125-26-333831 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-333813 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0001493152-26-035622 | View SEC Doc Filr Page |
| EFFECT | 2026-07-28 | — | EFFECT Filing | 9999999995-26-002481 | View SEC Doc Filr Page |
| 424B3 | 2026-07-28 | — | 424B3 | 0001193125-26-321196 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310983 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310982 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310980 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310978 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310970 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310969 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310967 | View SEC Doc Filr Page |
| 4/A | 2026-07-21 | 2026-06-12 | 4/A | 0001193125-26-310965 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-20 | — | SCHEDULE 13D/A Filing | 0000947871-26-000713 | View SEC Doc Filr Page |